These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 17057269)

  • 41. Oxybutynin transdermal system improves the quality of life in adults with overactive bladder: a multicentre, community-based, randomized study.
    Sand P; Zinner N; Newman D; Lucente V; Dmochowski R; Kelleher C; Dahl NV
    BJU Int; 2007 Apr; 99(4):836-44. PubMed ID: 17187655
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Topical atropine sulfate for the treatment of axillary hyperhidrosis.
    Grimalt R; Domínguez Tordera P; Callejas MA
    J Cosmet Dermatol; 2006 Dec; 5(4):294-6. PubMed ID: 17716247
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Individualized Dosing of Oral Oxybutynin for the Treatment of Primary Focal Hyperhidrosis in Children and Teenagers.
    Del Boz J; Millán-Cayetano JF; Blázquez-Sánchez N; de Troya M
    Pediatr Dermatol; 2016 May; 33(3):327-31. PubMed ID: 27122197
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Preliminary Experience with Transdermal Oxybutynin Patches for Hyperhidrosis.
    Bergón-Sendín M; Pulido-Pérez A; Sáez-Martín LC; Suárez-Fernández R
    Actas Dermosifiliogr; 2016 Dec; 107(10):845-850. PubMed ID: 27497508
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long-term results of oxybutynin treatment for palmar hyperhidrosis.
    Wolosker N; Teivelis MP; Krutman M; de Paula RP; de Campos JR; Kauffman P; Puech-Leão P
    Clin Auton Res; 2014 Dec; 24(6):297-303. PubMed ID: 25427685
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Transdermal oxybutynin: sticking to the facts.
    Cartwright R; Cardozo L
    Eur Urol; 2007 Apr; 51(4):907-14; discussion 914. PubMed ID: 17157979
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Use of oral glycopyrronium bromide in hyperhidrosis.
    Bajaj V; Langtry JA
    Br J Dermatol; 2007 Jul; 157(1):118-21. PubMed ID: 17459043
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Oxybutynin-Kentera].
    Duh D; Vandevijver A
    J Pharm Belg; 2007; 62(3):99-100. PubMed ID: 17955962
    [No Abstract]   [Full Text] [Related]  

  • 49. Oxybutynin for hyperhidrosis.
    Lefrandt JD; Maurer JM
    Neth J Med; 2007 Oct; 65(9):356. PubMed ID: 17954957
    [No Abstract]   [Full Text] [Related]  

  • 50. (S)-oxybutynin (Sepracor).
    Dmochowski RR
    Curr Opin Investig Drugs; 2002 Oct; 3(10):1508-11. PubMed ID: 12431028
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Improved efficacy of extended release oxybutynin in children with persistent daytime urinary incontinence converted from regular oxybutynin.
    Van Arendonk KJ; Knudson MJ; Austin JC; Cooper CS
    Urology; 2006 Oct; 68(4):862-5. PubMed ID: 17070368
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An alternative to treat palmar hyperhidrosis: use of oxybutynin.
    Wolosker N; de Campos JR; Kauffman P; Neves S; Yazbek G; Jatene FB; Puech-Leão P
    Clin Auton Res; 2011 Dec; 21(6):389-93. PubMed ID: 21688168
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of electric stimulation and oxybutynin chloride in management of overactive bladder with special reference to urinary urgency: a randomized placebo-controlled trial.
    Wang AC; Chih SY; Chen MC
    Urology; 2006 Nov; 68(5):999-1004. PubMed ID: 17113893
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hallucinations after hypospadias repair.
    Swana HS; Youmans SL; Kogan BA; Bogetz MS
    J Pediatr Surg; 2006 Mar; 41(3):e33-5. PubMed ID: 16516613
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Propantheline bromide in the management of hyperhidrosis associated with spinal cord injury.
    Canaday BR; Stanford RH
    Ann Pharmacother; 1995 May; 29(5):489-92. PubMed ID: 7655132
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Oral Oxybutynin for Local and Multifocal Hyperhidrosis: A Multicenter Study.
    Toledo-Pastrana T; Márquez-Enríquez J; Millán-Cayetano JF
    Actas Dermosifiliogr; 2017; 108(6):597-599. PubMed ID: 28388990
    [No Abstract]   [Full Text] [Related]  

  • 57. Long-term results of oxybutynin use in treating facial hyperhidrosis.
    Wolosker N; Teivelis MP; Krutman M; Campbell TP; Kauffman P; Campos JR; Puech-Leão P
    An Bras Dermatol; 2014; 89(6):912-6. PubMed ID: 25387496
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Adjusting oral oxybutynin medication for hyperhidrosis to reflect seasonal temperature variations.
    Del Boz J; Millán-Cayetano JF; García-Montero P; García-Harana C; Rivas-Ruiz F; de Troya-Martín M
    Dermatol Ther; 2018 Jul; 31(4):e12615. PubMed ID: 29740900
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Superiority of thoracoscopic sympathectomy over medical management for the palmoplantar subset of severe hyperhidrosis.
    Baumgartner FJ; Bertin S; Konecny J
    Ann Vasc Surg; 2009; 23(1):1-7. PubMed ID: 18619780
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Oxybutynin in primary hyperhidrosis: A long-term real-life study.
    Almeida ART; Ferrari F; Restrepo MVS; Rocha VB
    Dermatol Ther; 2020 Nov; 33(6):e14344. PubMed ID: 32981151
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.